Umbilical cord blood transplantation

Umbilical Cord Blood Transplantation

Umbilical cord blood transplantation is a medical procedure that involves the use of blood collected from the umbilical cord and placenta after childbirth. This blood is rich in hematopoietic stem cells, which can be used to treat a variety of diseases, particularly those affecting the blood and immune system.

Overview

Umbilical cord blood is a valuable source of stem cells, which are the precursors to all blood cells. These stem cells can differentiate into red blood cells, white blood cells, and platelets. Cord blood transplantation is an alternative to bone marrow transplantation and peripheral blood stem cell transplantation.

History

The first successful umbilical cord blood transplant was performed in 1988 in France, where a patient with Fanconi anemia received a transplant from a sibling donor. Since then, the procedure has been used to treat a variety of conditions, including leukemia, lymphoma, and sickle cell disease.

Collection and Storage

Cord blood is collected immediately after birth, once the umbilical cord has been clamped and cut. The collection process is safe and painless for both the mother and the newborn. The collected blood is then processed and cryopreserved in a cord blood bank for future use.

Indications

Cord blood transplantation is primarily used to treat:

• Hematological malignancies such as acute lymphoblastic leukemia and acute myeloid leukemia.
• Bone marrow failure syndromes like aplastic anemia.
• Genetic disorders such as thalassemia and sickle cell anemia.
• Metabolic disorders like Hurler syndrome.

Advantages

• Availability: Cord blood is readily available and can be stored for future use.
• Reduced Risk of Graft-versus-Host Disease (GVHD): There is a lower incidence of GVHD compared to other types of transplants.
• Less Stringent HLA Matching: Cord blood transplants do not require as close a match between donor and recipient as bone marrow transplants.

Challenges

• Limited Cell Dose: The number of stem cells in a single cord blood unit is limited, which can be a challenge for adult patients.
• Engraftment Time: Cord blood transplants may take longer to engraft compared to other sources of stem cells.

Future Directions

Research is ongoing to improve the outcomes of cord blood transplantation. Techniques such as ex vivo expansion of stem cells and the use of multiple cord blood units are being explored to overcome current limitations.

Also see

• Stem cell transplantation
• Hematopoietic stem cell
• Graft-versus-host disease
• Cord blood bank

Resources

Latest articles - Umbilical cord blood transplantation

• Most recent articles
• Ongoing trials

Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on Umbilical cord blood transplantation for any updates.

‎